<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7181694/table_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 1</label>
  <p>Summary of Parkinson’s genes first identified in familial and early-onset cases of PD and risk factors.</p>
 </caption>
 <thead>
  <tr>
   <th colspan="1" rowspan="1" id="0-0-.">Gene (Chromosomal position)</th>
   <th colspan="1" rowspan="1" id="0-1-.">Gene product</th>
   <th colspan="1" rowspan="1" id="0-2-.">Function</th>
   <th colspan="1" rowspan="1" id="0-3-.">Inheritance</th>
   <th colspan="1" rowspan="1" id="0-4-.">Mutations studied in iPSC studies</th>
   <th colspan="1" rowspan="1" id="0-5-.">Reference (iPSC studies)</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td>SNCA (4q21)</td>
   <td>a-synuclein</td>
   <td>Suppression of apoptosis, chaperone activity, antioxidation, neuronal differentiation, regulation of DA biosynthesis</td>
   <td>AD</td>
   <td>A53T; E46K; duplication; triplication</td>
   <td>
    <a ref-type="bibr" rid="CR28">28</a>, 
    <a ref-type="bibr" rid="CR30">30</a>, 
    <a ref-type="bibr" rid="CR33">33</a>– 
    <a ref-type="bibr" rid="CR35">35</a>, 
    <a ref-type="bibr" rid="CR41">41</a>, 
    <a ref-type="bibr" rid="CR42">42</a>, 
    <a ref-type="bibr" rid="CR49">49</a>, 
    <a ref-type="bibr" rid="CR55">55</a>, 
    <a ref-type="bibr" rid="CR60">60</a>, 
    <a ref-type="bibr" rid="CR66">66</a>, 
    <a ref-type="bibr" rid="CR73">73</a>, 
    <a ref-type="bibr" rid="CR80">80</a>, 
    <a ref-type="bibr" rid="CR83">83</a>, 
    <a ref-type="bibr" rid="CR84">84</a>, 
    <a ref-type="bibr" rid="CR89">89</a>, 
    <a ref-type="bibr" rid="CR90">90</a>, 
   </td>
  </tr>
  <tr>
   <td>PRKN(6q25.2-q27)</td>
   <td>Parkin</td>
   <td>Mitochondrial quality control</td>
   <td>AR</td>
   <td>V324A; T240R; R275W; R42P; −1 bp del 255A; Exon 3–4 del; Exon 2 del; Exon 3/5 del; Exon 6/7 del; Exon 2/4 del; Exon 5/6 del; Exon5 del; Exon 3 del</td>
   <td>
    <a ref-type="bibr" rid="CR24">24</a>, 
    <a ref-type="bibr" rid="CR29">29</a>, 
    <a ref-type="bibr" rid="CR31">31</a>, 
    <a ref-type="bibr" rid="CR39">39</a>, 
    <a ref-type="bibr" rid="CR40">40</a>, 
    <a ref-type="bibr" rid="CR42">42</a>, 
    <a ref-type="bibr" rid="CR54">54</a>, 
    <a ref-type="bibr" rid="CR64">64</a>, 
    <a ref-type="bibr" rid="CR68">68</a>, 
    <a ref-type="bibr" rid="CR71">71</a>, 
    <a ref-type="bibr" rid="CR74">74</a>, 
    <a ref-type="bibr" rid="CR76">76</a>, 
    <a ref-type="bibr" rid="CR77">77</a>, 
    <a ref-type="bibr" rid="CR84">84</a>, 
    <a ref-type="bibr" rid="CR88">88</a>, 
    <a ref-type="bibr" rid="CR91">91</a>, 
   </td>
  </tr>
  <tr>
   <td>PINK1 (1p35-p36)</td>
   <td>PTEN-induced kinase 1</td>
   <td>Mitochondrial quality control</td>
   <td>AR</td>
   <td>G309D; V170G; Q456X</td>
   <td>
    <a ref-type="bibr" rid="CR31">31</a>, 
    <a ref-type="bibr" rid="CR32">32</a>, 
    <a ref-type="bibr" rid="CR52">52</a>, 
    <a ref-type="bibr" rid="CR62">62</a>, 
    <a ref-type="bibr" rid="CR70">70</a>, 
    <a ref-type="bibr" rid="CR71">71</a>, 
    <a ref-type="bibr" rid="CR85">85</a>, 
   </td>
  </tr>
  <tr>
   <td>DJ-1 (1p36)</td>
   <td>DJ-1</td>
   <td>Protection against oxidative stress</td>
   <td>AR</td>
   <td>E46D</td>
   <td>
    <a ref-type="bibr" rid="CR27">27</a>
   </td>
  </tr>
  <tr>
   <td>LRRK2 (12q12)</td>
   <td>Leucine rich repeat kinase 2</td>
   <td>Membrane trafficking, mitochondrial membrane maintenance</td>
   <td>AD</td>
   <td>G2019S; R1441C; R1441G; I2020T</td>
   <td>
    <a ref-type="bibr" rid="CR26">26</a>, 
    <a ref-type="bibr" rid="CR32">32</a>, 
    <a ref-type="bibr" rid="CR37">37</a>, 
    <a ref-type="bibr" rid="CR38">38</a>, 
    <a ref-type="bibr" rid="CR42">42</a>– 
    <a ref-type="bibr" rid="CR44">44</a>, 
    <a ref-type="bibr" rid="CR46">46</a>– 
    <a ref-type="bibr" rid="CR48">48</a>, 
    <a ref-type="bibr" rid="CR50">50</a>, 
    <a ref-type="bibr" rid="CR51">51</a>, 
    <a ref-type="bibr" rid="CR53">53</a>, 
    <a ref-type="bibr" rid="CR56">56</a>, 
    <a ref-type="bibr" rid="CR57">57</a>, 
    <a ref-type="bibr" rid="CR61">61</a>, 
    <a ref-type="bibr" rid="CR65">65</a>, 
    <a ref-type="bibr" rid="CR78">78</a>, 
    <a ref-type="bibr" rid="CR79">79</a>, 
    <a ref-type="bibr" rid="CR82">82</a>, 
    <a ref-type="bibr" rid="CR84">84</a>, 
    <a ref-type="bibr" rid="CR86">86</a>, 
    <a ref-type="bibr" rid="CR87">87</a>, 
   </td>
  </tr>
  <tr>
   <td>ATP13A2 (1p36)</td>
   <td>Cation-transporting ATPase 13A2</td>
   <td>Cation homeostasis, lysosomal function</td>
   <td>AR</td>
   <td>N/A</td>
   <td>N/A</td>
  </tr>
  <tr>
   <td>VPS35 (16q11.2)</td>
   <td>Vacuolar protein sorting 35</td>
   <td>Recycling of membrane proteins between endosomes and the trans-Golgi network</td>
   <td>AD</td>
   <td>N/A</td>
   <td>N/A</td>
  </tr>
  <tr>
   <td>DNAJC6 (1p31.3)</td>
   <td>DNAJ subfamily C member 6</td>
   <td>Clathrin mediated endocytosis</td>
   <td>AR</td>
   <td>N/A</td>
   <td>N/A</td>
  </tr>
  <tr>
   <td>FBXO7 (22q12–q13)</td>
   <td>F-box protein 7</td>
   <td>Phosphorylation-dependent ubiquitination</td>
   <td>AR</td>
   <td>N/A</td>
   <td>N/A</td>
  </tr>
  <tr>
   <td>SYNJ1 (21q22.11)</td>
   <td>Synaptojanin-1</td>
   <td>Regulation of synaptic vesicle endocytosis</td>
   <td>AR</td>
   <td>N/A</td>
   <td>N/A</td>
  </tr>
  <tr>
   <td>PLA2G6 (22q12–q13)</td>
   <td>Phospholipase A2, group 6</td>
   <td>Phospholipid remodeling, mitochondrial function</td>
   <td>AR</td>
   <td>N/A</td>
   <td>N/A</td>
  </tr>
  <tr>
   <td>CHCHD2 (7p11.2)</td>
   <td>Coiled-coil-helix-coiled-coil-helix domain 2</td>
   <td>Regulation of mitochondrial metabolism under oxygen stress</td>
   <td>AD</td>
   <td>N/A</td>
   <td>N/A</td>
  </tr>
  <tr>
   <td>GIGYF2 (2q36–q37)</td>
   <td>GRB10 interacting GYF protein 2</td>
   <td>Negative regulation of cell growth</td>
   <td>AD</td>
   <td>N/A</td>
   <td>N/A</td>
  </tr>
  <tr>
   <td>Omi/HTRA2 (2p13)</td>
   <td>High-temperature requirement A2</td>
   <td>Neuroprotection</td>
   <td>AR</td>
   <td>N/A</td>
   <td>N/A</td>
  </tr>
  <tr>
   <td>VPS13C (15q22.2)</td>
   <td>Vacuolar protein sorting 13C</td>
   <td>Maintenance of mitochondrial function</td>
   <td>AR</td>
   <td>N/A</td>
   <td>N/A</td>
  </tr>
  <tr>
   <td>EIF4G1 (3q27.1)</td>
   <td>Eukaryotic translation initiation factor 4 gamma 1</td>
   <td>Regulation of mRNAs translation</td>
   <td>AD</td>
   <td>N/A</td>
   <td>N/A</td>
  </tr>
  <tr>
   <td>UCHL1 (4p13)</td>
   <td>Ubiquitin C-terminal hydrolase L1</td>
   <td>Ubiquitin–proteasome system and neuronal survival</td>
   <td>AD</td>
   <td>N/A</td>
   <td>N/A</td>
  </tr>
  <tr>
   <td>GBA (1q21)</td>
   <td>Glucosylceramidase Beta</td>
   <td>Lysosomal function</td>
   <td>RF</td>
   <td>N370S; L444P; RecNil</td>
   <td>
    <a ref-type="bibr" rid="CR30">30</a>, 
    <a ref-type="bibr" rid="CR36">36</a>, 
    <a ref-type="bibr" rid="CR58">58</a>, 
    <a ref-type="bibr" rid="CR59">59</a>, 
    <a ref-type="bibr" rid="CR69">69</a>, 
    <a ref-type="bibr" rid="CR84">84</a>, 
   </td>
  </tr>
  <tr>
   <td>MAPT (17q21.31)</td>
   <td>Microtubule-associated protein Tau</td>
   <td>Modulates the stability of axonal microtubules</td>
   <td>RF</td>
   <td>Haplotype H1/H2</td>
   <td>
    <a ref-type="bibr" rid="CR25">25</a>
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p>N/A indicates mutations not studied in iPSC-PD studies.</p>
  <p>
   <i>AD</i> autosomal dominant; 
   <i>AR</i> autosomal recessive; 
   <i>RF</i> risk factor; 
   <i>del</i> deletion. 
  </p>
 </tfoot>
</table>
